Tilray provides international cannabis update on milestone german cannabis legalization

Germany's de-scheduling of cannabis opens path to new opportunities for tilray in potential $3bn medical market european union medical cannabis market now projected to become $45bn new york and neumÜnster, germany, feb. 28, 2024 (globe newswire) -- tilray brands, inc. (“tilray”) (nasdaq: tlry; tsx: tlry), a global leader in cannabis research, cultivation, production, and distribution, today provides an update on germany's milestone cannabis legalization and what it means for the future of cannabis in europe and for tilray. as a global leader in the legalized medical and adult-use cannabis markets and a market leader in medical cannabis across europe, with a leading market share in germany, tilray is bullish on the positive paradigm shift that the new german drug policy creates for the future of cannabis in europe.
TLRY Ratings Summary
TLRY Quant Ranking